Erectile Dysfunction Medication Prescription and Condomless Intercourse in HIV-Infected Men Who Have Sex with Men in the United States

Overview

Journal AIDS Behav

Specialty Infectious Diseases

Date 2016 Sep 18

PMID 27637499

Citations 3

Authors

Xia Lin

Christine L Mattson

Mark Freedman

Jacek Skarbinski

Affiliations

Soon will be listed here.

Abstract

Using nationally representative data, we assessed the prevalence of erectile dysfunction medication (EDM) prescription, and its association with insertive condomless anal intercourse (CAI) with an HIV-serodiscordant partner among sexually-active HIV-infected men who have sex with men (MSM) receiving medical care in the United States. Overall, 14 % (95 % CI 12-16) were prescribed EDM and 21 % (95 % CI 19-23) engaged in serodiscordant CAI. MSM who were prescribed EDM were more likely to engage in insertive CAI with a serodiscordant casual partner than those not prescribed EDM after adjusting for illicit drug use before or during sex (adjusted prevalence ratio = 1.38; 95 % CI 1.01-1.88). We found no association with main partners. Only 40 % (95 % CI 36-44) of MSM prescribed EDM received risk-reduction counseling from healthcare professionals. Risk-reduction counseling should be provided at least annually to all HIV-infected persons as recommended, especially at the time of EDM prescription.

Citing Articles

Interventions, Barriers, and Facilitators to Address the Sexual Problems of Gay, Bisexual and Other Men Who Have Sex with Men Living with HIV: A Rapid Scoping Review.

Avallone F, Engler K, Cox J, Hickson F, Lebouche B AIDS Behav. 2024; 28(2):450-472.

PMID: 38296920 DOI: 10.1007/s10461-023-04237-3.

Longitudinal Event-Level Analysis of Gay and Bisexual Men's Anal Sex Versatility: Behavior, Roles, and Substance Use.

Shaw L, Wang L, Cui Z, Rich A, Armstrong H, Lachowsky N J Sex Res. 2019; 56(9):1136-1146.

PMID: 31461383 PMC: 6791743. DOI: 10.1080/00224499.2019.1652238.

Erectile Dysfunction Medication Prescription: STI and Risk Behavior in Men with HIV.

Heudebert J, Tamhane A, Burkholder G, Dionne-Odom J J Sex Med. 2019; 16(5):691-700.

PMID: 30926519 PMC: 6487224. DOI: 10.1016/j.jsxm.2019.02.007.

References

Colson A, Keller M, Sax P, Pettus P, Platt R, Choo P . Male sexual dysfunction associated with antiretroviral therapy. J Acquir Immune Defic Syndr. 2002; 30(1):27-32. DOI: 10.1097/00042560-200205010-00004. View

Gardner L, Marks G, ODaniels C, Wilson T, Golin C, Wright J . Implementation and evaluation of a clinic-based behavioral intervention: positive steps for patients with HIV. AIDS Patient Care STDS. 2008; 22(8):627-35. DOI: 10.1089/apc.2007.0210. View

Moreau-Gruet F, Jeannin A, Dubois-Arber F, Spencer B . Management of the risk of HIV infection in male homosexual couples. AIDS. 2001; 15(8):1025-35. DOI: 10.1097/00002030-200105250-00011. View

Asboe D, Catalan J, Mandalia S, Dedes N, Florence E, Schrooten W . Sexual dysfunction in HIV-positive men is multi-factorial: a study of prevalence and associated factors. AIDS Care. 2007; 19(8):955-65. DOI: 10.1080/09540120701209847. View

Kim A, Kent C, Klausner J . Increased risk of HIV and sexually transmitted disease transmission among gay or bisexual men who use Viagra, San Francisco 2000-2001. AIDS. 2002; 16(10):1425-8. DOI: 10.1097/00002030-200207050-00017. View

McLean J, Boulton M, Brookes M, Lakhani D, Fitzpatrick R, Dawson J . Regular partners and risky behaviour: why do gay men have unprotected intercourse?. AIDS Care. 1994; 6(3):331-41. DOI: 10.1080/09540129408258645. View

Pantalone D, Bimbi D, Parsons J . Motivations for the recreational use of erectile enhancing medications in urban gay and bisexual men. Sex Transm Infect. 2008; 84(6):458-62. PMC: 3152748. DOI: 10.1136/sti.2008.031476. View

Chu P, McFarland W, Gibson S, Weide D, Henne J, Miller P . Viagra use in a community-recruited sample of men who have sex with men, San Francisco. J Acquir Immune Defic Syndr. 2003; 33(2):191-3. DOI: 10.1097/00126334-200306010-00012. View

Prestage G, Jin F, Kippax S, Zablotska I, Imrie J, Grulich A . Use of illicit drugs and erectile dysfunction medications and subsequent HIV infection among gay men in Sydney, Australia. J Sex Med. 2009; 6(8):2311-20. DOI: 10.1111/j.1743-6109.2009.01323.x. View

10.

Kroenke K, Strine T, Spitzer R, Williams J, Berry J, Mokdad A . The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2008; 114(1-3):163-73. DOI: 10.1016/j.jad.2008.06.026. View

11.

Crum N, Furtek K, Olson P, Amling C, Wallace M . A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras: diagnosis, pathogenesis, and management. AIDS Patient Care STDS. 2005; 19(10):655-71. DOI: 10.1089/apc.2005.19.655. View

12.

Spindler H, Scheer S, Chen S, Klausner J, Katz M, Valleroy L . Viagra, methamphetamine, and HIV risk: results from a probability sample of MSM, San Francisco. Sex Transm Dis. 2007; 34(8):586-91. DOI: 10.1097/01.olq.0000258339.17325.93. View

13.

Shaeer O . The Global Online Sexuality Survey (GOSS): the United States of America in 2011 chapter II: phosphodiesterase inhibitors utilization among English speakers. J Sex Med. 2012; 10(2):532-40. DOI: 10.1111/j.1743-6109.2012.02972.x. View

14.

Lallemand F, Salhi Y, Linard F, Giami A, Rozenbaum W . Sexual dysfunction in 156 ambulatory HIV-infected men receiving highly active antiretroviral therapy combinations with and without protease inhibitors. J Acquir Immune Defic Syndr. 2002; 30(2):187-90. DOI: 10.1097/00042560-200206010-00007. View

15.

Crum-Cianflone N, Bavaro M, Hale B, Amling C, Truett A, Brandt C . Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDS. 2007; 21(1):9-19. DOI: 10.1089/apc.2006.0071. View

16.

Hirshfield S, Remien R, Humberstone M, Walavalkar I, Chiasson M . Substance use and high-risk sex among men who have sex with men: a national online study in the USA. AIDS Care. 2004; 16(8):1036-47. DOI: 10.1080/09540120412331292525. View

17.

Selvin E, Burnett A, Platz E . Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007; 120(2):151-7. DOI: 10.1016/j.amjmed.2006.06.010. View

18.

Samji H, Cescon A, Hogg R, Modur S, Althoff K, Buchacz K . Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013; 8(12):e81355. PMC: 3867319. DOI: 10.1371/journal.pone.0081355. View

19.

Patel P, Borkowf C, Brooks J, Lasry A, Lansky A, Mermin J . Estimating per-act HIV transmission risk: a systematic review. AIDS. 2014; 28(10):1509-19. PMC: 6195215. DOI: 10.1097/QAD.0000000000000298. View

20.

Perez I, Moreno T, Navarro F, Santos J, Palacios R . Prevalence and factors associated with erectile dysfunction in a cohort of HIV-infected patients. Int J STD AIDS. 2013; 24(9):712-5. DOI: 10.1177/0956462413482423. View